Top Markets
Coin of the day
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited

0950
Rang in Aktien #22620
Lee's Pharmaceutical Holdings Limited, an investment holding company, develops,... Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products in the People's Republic of China, Hong Kong, and internationally. It focuses on various disease areas, such as cardiovascular, woman's health, pediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates in Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells Nadroparin Calcium injection and Livaracine to treat blood clots and deep vein thrombosis; Yallaferon for viral infection; Slounase for hemostasis; Socazolimab Injection for Recurrent or metastatic cervical cancer; Treprostinil injection for pulmonary arterial hypertension; fondaparinux sodium injection for deep vein thrombosis; and Sodium Phenylbutyrate Granules to treat urea cycle disorders; Apremilast Tablets for Plaque psoriasis; and Azilsartan Tablets for hypertension. The Licensed-In Products segment offers Sancuso for chemotherapy induced nausea and vomiting; Bredinin to treat Immunosuppression in renal transplantation; Centraxal Plus for acute otitis media with tympanostomy tubes; and Ferplex to treat iron deficiency anemia. This segment also offers Intrarosa for vulvovaginal atrophy; Adasuve for agitation associated with schizophrenia or bipolar I disorder in adults; Mictonorm for urinary incontinence; Natulan for Stage III and IV Hodgkin's disease; Lutrate for Prostate cancer; Nitric Oxide for Inhalation for Hypoxic respiratory failure associated with pulmonary hypertension; Omacor to treat Omega-3-acid ethyl esters; Zanidip for hypertension; Readyfusor for post-operative pain management; Teglutik to treat Amyotrophic lateral sclerosis; Trittico for insomnia/depression; Dicoflor and VSL#3 for probiotics; and Zingo for topical local analgesics. The company was founded in 1994 and is headquartered in Sha Tin, Hong Kong.
Aktienkurs
$0.1458359
Zuletzt synchronisiert: 2026-08-21
Marktkapitalisierung
$85.87M
Veränderung (1 Tag)
-1.30%
Veränderung (1 Jahr)
-38.40%
Land
HK
Handel Lee's Pharmaceutical Holdings Limited (0950)

Kategorie

Preis 0950 mit Marktkapitalisierung von B
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
0950
$0.1458359
Marktkapitalisierung von Lee's Pharmaceutical Holdings Limited(0950)
Marktkapitalisierung: $85.87M
Mit Stand August 2026 hat Lee's Pharmaceutical Holdings Limited eine Marktkapitalisierung von $85.87M. Das macht Lee's Pharmaceutical Holdings Limited laut unseren Daten zum 22620th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von Lee's Pharmaceutical Holdings Limited von 2002 bis 2026
0950 im Vergleich zu den Top 5 der beliebtesten stocks
Preis für 0950 Vermögenswert B Marktkapitalisierung von B Ergebnisse
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$8,850.34 $85.87M
$5.211T +6,068,594.72%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,721.62 $85.87M
$4.547T +5,294,634.25%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$7,069.03 $85.87M
$4.162T +4,847,147.71%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$6,101.55 $85.87M
$3.593T +4,183,743.16%
Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited
$4,743.03 $85.87M
$2.793T +3,252,208.68%